Authors: BARF T WIKSTROM H PAUWELS PJ PALMIER C TARDIF S LUNDMARK M SUNDELL S

Citation: T. Barf et al., 5-(SULFONYL)OXY-TRYPTAMINES AND ETHYLAMINO SIDE-CHAIN RESTRICTED DERIVATIVES - STRUCTURE-AFFINITY RELATIONSHIPS FOR H5-HT1B AND H5-HT1D RECEPTORS, Bioorganic & medicinal chemistry, 6(9), 1998, pp. 1469-1479

Authors: HALL H LUNDKVIST C HALLDIN C FARDE L PIKE VW MCCARRON JA FLETCHER A CLIFFE IA BARF T WIKSTROM H SEDVALL G

Citation: H. Hall et al., AUTORADIOGRAPHIC LOCALIZATION OF 5-HT1A RECEPTORS IN THE POSTMORTEM HUMAN BRAIN USING [H-3] WAY-100635 AND [C-11] WAY-100635, Brain research, 745(1-2), 1997, pp. 96-108

Authors: OSMAN S LUNDKVIST C PIKE VW HALLDIN C MCCARRON JA SWAHN CG GINOVART N LUTHRA SK BENCH CJ GRASBY PM WIKSTROM H BARF T CLIFFE IA FLETCHER A FARDE L

Citation: S. Osman et al., CHARACTERIZATION OF THE RADIOACTIVE METABOLITES OF THE 5-HT1A RECEPTOR RADIOLIGAND, [O-METHYL-C-11]WAY-100635, IN MONKEY AND HUMAN PLASMA BY HPLC - COMPARISON OF THE BEHAVIOR OF AN IDENTIFIED RADIOACTIVE METABOLITE WITH PARENT RADIOLIGAND IN MONKEY USING PET, Nuclear medicine and biology, 23(5), 1996, pp. 627-634

Authors: SAXENA PR DEVRIES P HEILIGERS JPC VANDENBRINK AM BAX WA BARF T WIKSTROM H

Citation: Pr. Saxena et al., INVESTIGATIONS WITH GMC2021 IN EXPERIMENTAL-MODELS PREDICTIVE OF ANTIMIGRAINE ACTIVITY AND CORONARY SIDE-EFFECT POTENTIAL, European journal of pharmacology, 312(1), 1996, pp. 53-62

Authors: BARF T KORTE SM KORTEBOUWS G SONESSON C DAMSMA G BOHUS B WIKSTROM H

Citation: T. Barf et al., POTENTIAL ANXIOLYTIC PROPERTIES OF R-(-8-OSO2CF3-PAT, A 5-HT1A RECEPTOR AGONIST()), European journal of pharmacology, 297(3), 1996, pp. 205-211

Authors: SONESSON C BARF T NILSSON J DIJKSTRA D CARLSSON A SVENSSON K SMITH MW MARTIN IJ DUNCAN JN KING LJ WIKSTROM H

Citation: C. Sonesson et al., SYNTHESIS AND EVALUATION OF PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES OF MONOPROPYL ANALOGS OF -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, AND 8-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN - CENTRAL DOPAMINE ANDSEROTONIN RECEPTOR ACTIVITY, Journal of medicinal chemistry, 38(8), 1995, pp. 1319-1329